124 related articles for article (PubMed ID: 33006903)
1. Targeting the GLI family of transcription factors for the development of anti-cancer drugs.
Dusek CO; Hadden MK
Expert Opin Drug Discov; 2021 Mar; 16(3):289-302. PubMed ID: 33006903
[TBL] [Abstract][Full Text] [Related]
2. 8-Hydroxyquinoline derivatives suppress GLI1-mediated transcription through multiple mechanisms.
Wen J; Charan Dash R; Zaino AM; Harrahill NJ; Calhoun JT; Dusek CO; Morel SR; Russolillo M; Kyle Hadden M
Bioorg Chem; 2023 Mar; 132():106387. PubMed ID: 36724660
[TBL] [Abstract][Full Text] [Related]
3. Targeting GLI Transcription Factors in Cancer.
Didiasova M; Schaefer L; Wygrecka M
Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137
[TBL] [Abstract][Full Text] [Related]
4. Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer.
Xie H; Paradise BD; Ma WW; Fernandez-Zapico ME
Cells; 2019 Apr; 8(5):. PubMed ID: 31035664
[TBL] [Abstract][Full Text] [Related]
5. Role of Glioma-associated GLI1 Oncogene in Carcinogenesis and Cancertargeted Therapy.
Wu J; Di D; Zhao C; Liu Y; Chen H; Gong Y; Zhao X; Chen H
Curr Cancer Drug Targets; 2018; 18(6):558-566. PubMed ID: 29189160
[TBL] [Abstract][Full Text] [Related]
6. Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing.
Zhang R; Wu J; Ferrandon S; Glowacki KJ; Houghton JA
Oncotarget; 2016 Dec; 7(49):80190-80207. PubMed ID: 27863397
[TBL] [Abstract][Full Text] [Related]
7. Bicyclic Imidazolium Inhibitors of Gli Transcription Factor Activity.
Hom ME; Ondrus AE; Sakata-Kato T; Rack PG; Chen JK
ChemMedChem; 2020 Jun; 15(12):1044-1049. PubMed ID: 32268014
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells.
Ji Z; Mei FC; Xie J; Cheng X
J Biol Chem; 2007 May; 282(19):14048-55. PubMed ID: 17353198
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
Rovida E; Stecca B
Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor GLI1 cooperates with the chromatin remodeler SMARCA2 to regulate chromatin accessibility at distal DNA regulatory elements.
Safgren SL; Olson RLO; Vrabel AM; Almada LL; Marks DL; Hernandez-Alvarado N; Gaspar-Maia A; Fernandez-Zapico ME
J Biol Chem; 2020 Jun; 295(26):8725-8735. PubMed ID: 32376693
[TBL] [Abstract][Full Text] [Related]
11. Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications.
Grund-Gröschke S; Stockmaier G; Aberger F
Cell Commun Signal; 2019 Dec; 17(1):172. PubMed ID: 31878932
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors.
Benvenuto M; Masuelli L; De Smaele E; Fantini M; Mattera R; Cucchi D; Bonanno E; Di Stefano E; Frajese GV; Orlandi A; Screpanti I; Gulino A; Modesti A; Bei R
Oncotarget; 2016 Feb; 7(8):9250-70. PubMed ID: 26843616
[TBL] [Abstract][Full Text] [Related]
13. Gli1-Mediated Regulation of Sox2 Facilitates Self-Renewal of Stem-Like Cells and Confers Resistance to EGFR Inhibitors in Non-Small Cell Lung Cancer.
Bora-Singhal N; Perumal D; Nguyen J; Chellappan S
Neoplasia; 2015 Jul; 17(7):538-51. PubMed ID: 26297432
[TBL] [Abstract][Full Text] [Related]
14. GLI1 Inhibitors Identified by Target Protein Oriented Natural Products Isolation (TPO-NAPI) with Hedgehog Inhibition.
Arai MA; Ochi F; Makita Y; Chiba T; Higashi K; Suganami A; Tamura Y; Toida T; Iwama A; Sadhu SK; Ahmed F; Ishibashi M
ACS Chem Biol; 2018 Sep; 13(9):2551-2559. PubMed ID: 30160475
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold.
Berardozzi S; Bernardi F; Infante P; Ingallina C; Toscano S; De Paolis E; Alfonsi R; Caimano M; Botta B; Mori M; Di Marcotullio L; Ghirga F
Eur J Med Chem; 2018 Aug; 156():554-562. PubMed ID: 30025349
[TBL] [Abstract][Full Text] [Related]
16. Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma.
Po A; Silvano M; Miele E; Capalbo C; Eramo A; Salvati V; Todaro M; Besharat ZM; Catanzaro G; Cucchi D; Coni S; Di Marcotullio L; Canettieri G; Vacca A; Stassi G; De Smaele E; Tartaglia M; Screpanti I; De Maria R; Ferretti E
Oncogene; 2017 Aug; 36(32):4641-4652. PubMed ID: 28368412
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling.
Riobo NA; Haines GM; Emerson CP
Cancer Res; 2006 Jan; 66(2):839-45. PubMed ID: 16424016
[TBL] [Abstract][Full Text] [Related]
18. Nanoquinacrine caused apoptosis in oral cancer stem cells by disrupting the interaction between GLI1 and β catenin through activation of GSK3β.
Nayak A; Siddharth S; Das S; Nayak D; Sethy C; Kundu CN
Toxicol Appl Pharmacol; 2017 Sep; 330():53-64. PubMed ID: 28720477
[TBL] [Abstract][Full Text] [Related]
19. The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma.
Lospinoso Severini L; Ghirga F; Bufalieri F; Quaglio D; Infante P; Di Marcotullio L
Expert Opin Ther Targets; 2020 Nov; 24(11):1159-1181. PubMed ID: 32990091
[TBL] [Abstract][Full Text] [Related]
20. GLI1, a master regulator of the hallmark of pancreatic cancer.
Kasai K
Pathol Int; 2016 Dec; 66(12):653-660. PubMed ID: 27862693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
